Novartis stocks drug cabinet with "Big-3" arthritis blockbusters

ZURICH (Reuters) - Switzerland's Novartis is stocking up cheaper versions of the world's top-selling arthritis medicines, hoping a broad portfolio gives it an edge on rivals with narrower offerings.